Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

Clinical trial NCT02406183 · COMPLETED

Trial details

NCT number: NCT02406183
Sponsor: Radiotherapie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Effects of Immunotherapy Adverse Effect of Radiation Therapy

Start date: 2015-03-01
Primary completion: 2016-08-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.